Smith & Nephew plc (LON:SN)’s share price fell 0% during trading on Thursday . The company traded as low as GBX 1,274 ($17.15) and last traded at GBX 1,279 ($17.21). 1,544,861 shares were traded during trading, a decline of 44% from the average session volume of 2,740,000 shares. The stock had previously closed at GBX 1,279 ($17.21).
Several brokerages recently commented on SN. Deutsche Bank upped their target price on Smith & Nephew from GBX 1,200 ($16.15) to GBX 1,315 ($17.70) and gave the company a “hold” rating in a research report on Monday, October 23rd. J P Morgan Chase & Co upped their target price on Smith & Nephew from GBX 1,361 ($18.32) to GBX 1,382 ($18.60) and gave the company a “neutral” rating in a research report on Thursday, October 19th. Jefferies Group restated a “buy” rating and set a GBX 1,515 ($20.39) target price on shares of Smith & Nephew in a research report on Monday, November 6th. Citigroup restated a “sell” rating and set a GBX 1,160 ($15.61) target price on shares of Smith & Nephew in a research report on Thursday, October 12th. Finally, Goldman Sachs Group restated a “neutral” rating and set a GBX 1,380 ($18.57) target price on shares of Smith & Nephew in a research report on Monday, September 11th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of GBX 1,315.82 ($17.71).
The stock has a market cap of $11,270.00 and a price-to-earnings ratio of 1,771.23.
ILLEGAL ACTIVITY NOTICE: “Smith & Nephew (SN) Trading Down 0%” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2017/12/23/smith-nephew-sn-trading-down-0.html.
About Smith & Nephew
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.